- How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinions
[作者:Offidani, M; Corvatta, L; Morabito, F; Gentile, M; Musto, P; Leoni, P; Palumbo, A,期刊:Expert opinion on investigational drugs, 页码:779-793 , 文章类型: Review,,卷期:2011年20-6]
- Introduction: Relapsed/refractory multiple myeloma (rrMM) remains a difficult condition to treat despite the availability of new drugs. This review aims to provide evidence to guide physicians in the choice of salvage th...
- Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments
[作者:Kang, YS; Cha, JJ; Hyun, YY; Cha, DR,期刊:Expert opinion on investigational drugs, 页码:745-756 , 文章类型: Review,,卷期:2011年20-6]
- Introduction: C-C chemokine ligand 2 (CCL2), also known as monocyte chemoattractant protein-1, and its receptor, C-C chemokine receptor 2 (CCR2), play important roles in various inflammatory diseases. Recently, it has be...
|